Literature DB >> 17547583

COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.

Katherine E Burdick1, Birgit Funke, Joseph F Goldberg, John A Bates, Judith Jaeger, Raju Kucherlapati, Anil K Malhotra.   

Abstract

OBJECTIVES: Bipolar disorder (BPD) is an affective disorder characterized by episodes of depression and mania. Cognitive impairment in patients with BPD is common and recent data suggest that it may represent a trait-like feature of the illness, as it persists during periods of wellness and co-segregates in families of bipolar patients. This suggests an underlying genetic predisposition towards cognitive impairment in patients with BPD; however, there have been few studies investigating the effects of candidate genes on this symptom domain. The catechol-O-methyl transferase (COMT) gene is located on chromosome 22q11 and is involved in the metabolism of dopamine and norepinephrine. A large body of evidence suggests that COMT is associated with cognitive performance in patients with schizophrenia and in healthy volunteers but there have been no reports of its relationship to cognition in BPD.
METHODS: We genotyped 52 Caucasian bipolar I probands and 102 Caucasian healthy controls across four single nucleotide polymorphisms (SNPs) within the COMT gene and administered a cognitive screening battery. We first assessed the relationship between COMT genotype and diagnosis and then tested for effects on cognition.
RESULTS: We observed a modest but significant association between SNP rs165599 and BPD I, with the g allele being over-represented in cases versus controls (odds ratio, OR = 2.41; allelic p = 0.02; genotypic p = 0.04). Further, we found a relationship between the risk allele at this SNP and poorer performance on measures of verbal memory [California Verbal Learning Test (CVLT) Trials 1-5; p = 0.005, eta(2) = 0.07] particularly with regard to prefrontal aspects of learning (CVLT semantic cluster; p = 0.037, eta(2) = 0.04) in patients with BPD and in healthy controls. The common Val158Met polymorphism was not associated with diagnosis (p = 0.32) or cognition in our sample.
CONCLUSIONS: These data suggest that COMT genetic variation at SNP rs165599 is associated with BPD I and influences prefrontal aspects of verbal memory in bipolar patients and healthy controls.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17547583     DOI: 10.1111/j.1399-5618.2007.00384.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  28 in total

1.  Interactions among catechol-O-methyltransferase genotype, parenting, and sex predict children's internalizing symptoms and inhibitory control: Evidence for differential susceptibility.

Authors:  Michael J Sulik; Nancy Eisenberg; Tracy L Spinrad; Kathryn Lemery-Chalfant; Gregory Swann; Kassondra M Silva; Mark Reiser; Daryn A Stover; Brian C Verrelli
Journal:  Dev Psychopathol       Date:  2014-08-27

Review 2.  Genetics of bipolar disorder.

Authors:  Jordan W Smoller; Erica Gardner-Schuster
Journal:  Curr Psychiatry Rep       Date:  2007-12       Impact factor: 5.285

Review 3.  Early institutionalization: neurobiological consequences and genetic modifiers.

Authors:  Margaret Sheridan; Stacy Drury; Kate McLaughlin; Alisa Almas
Journal:  Neuropsychol Rev       Date:  2010-11-03       Impact factor: 7.444

4.  The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis.

Authors:  Zhao Zhang; Klaus Lindpaintner; Ronglin Che; Zangdong He; Peng Wang; Ping Yang; Guoyin Feng; Lin He; Yongyong Shi
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

5.  Shared intermediate phenotypes for schizophrenia and bipolar disorder: neuroanatomical features of subtypes distinguished by executive dysfunction.

Authors:  Alana M Shepherd; Yann Quidé; Kristin R Laurens; Nicole O'Reilly; Jesseca E Rowland; Philip B Mitchell; Vaughan J Carr; Melissa J Green
Journal:  J Psychiatry Neurosci       Date:  2015-01       Impact factor: 6.186

Review 6.  COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation.

Authors:  Elisa Ira; Martina Zanoni; Mirella Ruggeri; Paola Dazzan; Sarah Tosato
Journal:  J Psychiatry Neurosci       Date:  2013-11       Impact factor: 6.186

Review 7.  Impairment in functional capacity as an endophenotype candidate in severe mental illness.

Authors:  Philip D Harvey; Margaret M McClure; Thomas L Patterson; John A McGrath; Ann E Pulver; Christopher R Bowie; Larry J Siever
Journal:  Schizophr Bull       Date:  2011-05-11       Impact factor: 9.306

Review 8.  Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy.

Authors:  Katherine E Burdick; Raphael J Braga; Joseph F Goldberg; Anil K Malhotra
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder.

Authors:  Georgina Guilera; Oscar Pino; Juana Gómez-Benito; J Emilio Rojo; Eduard Vieta; Rafael Tabarés-Seisdedos; Nuria Segarra; Anabel Martínez-Arán; Manuel Franco; Manuel J Cuesta; Benedicto Crespo-Facorro; Miguel Bernardo; Scot E Purdon; Teresa Díez; Javier Rejas
Journal:  Health Qual Life Outcomes       Date:  2009-04-01       Impact factor: 3.186

10.  Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder.

Authors:  Richard C McEachin; Nancy L Saccone; Scott F Saccone; Yelena D Kleyman-Smith; Tiara Kar; Rajesh K Kare; Alex S Ade; Maureen A Sartor; James D Cavalcoli; Melvin G McInnis
Journal:  BMC Med Genet       Date:  2010-01-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.